Knowledge and Network Typology
This chapter develops a matrix that plots variations in open/tacit versus closed/codified system architectures supporting or limiting innovation capacity and new business creation in targeted sectors. Aggregate global and microlevel data are analyzed to identify concentrations of innovation and firm level activity. Emerging hubs of knowledge and firm creation in biomedical industries, including biopharmaceuticals, are identified. Aggregate data is supplemented with firm level case studies and interviews with entrepreneurs, government officials, incubation managers, and investors. The conceptual framework outlined in Chapter 1 and specified in Chapter 2 provides the lens through which innovation and entrepreneurship strategies in China, India, Japan, and Singapore are viewed. The analysis is supplemented with firm level entrepreneurial case studies.
Beyond Technonationalism